Literature DB >> 9754584

Human IgA- and IgM-secreting intestinal plasma cells carry heavily mutated VH region genes.

M Fischer1, R Küppers.   

Abstract

Single IgA- or IgM-secreting plasma cells were isolated from histological sections of human jejunum and terminal ileum, and Ig heavy chain variable (VH) region genes were amplified and sequenced. Taken together, 62 of 63 cells analyzed harbored somatically mutated VH region genes, indicating that the vast majority of both IgA- and IgM-secreting intestinal plasma cells derive from germinal center B cells. On average, rearranged VH genes of IgA- and IgM-secreting plasma cells showed a mutation frequency of 9.0 % and 8.5 %, respectively, which exceeds the level of somatic mutation of V region genes carried by human memory B cells. Moreover, we detected deletions or insertions in the complementarity-determining regions of 5 of the 58 functional VH region genes analyzed, suggesting that these alterations may contribute to the diversification of the human antibody repertoire in the course of an immune reaction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9754584     DOI: 10.1002/(SICI)1521-4141(199809)28:09<2971::AID-IMMU2971>3.0.CO;2-3

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  16 in total

1.  Characteristics of IgVH genes used by human intestinal plasma cells from childhood.

Authors:  L Boursier; D K Dunn-Walters; J Spencer
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

2.  Isolation, maturational level, and functional capacity of human colon lamina propria plasma cells.

Authors:  F Medina; C Segundo; A Campos-Caro; I Salcedo; A García-Poley; J A Brieva
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

3.  The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific.

Authors:  Julia Benckert; Nina Schmolka; Cornelia Kreschel; Markus Josef Zoller; Andreas Sturm; Bertram Wiedenmann; Hedda Wardemann
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

4.  Molecular characterization of the cervical and systemic B-cell repertoire: Unique, yet overlapping, immune compartments of an HIV-1 resistant individual.

Authors:  Ryan G Gaudet; Felix Breden; Frank Plummer; Jody D Berry
Journal:  MAbs       Date:  2011-03-01       Impact factor: 5.857

5.  Analysis of the expressed immunoglobulin variable region heavy chain gene products in paraproteins from Iranian patients with multiple myeloma.

Authors:  S Gharagozloo; R A Sharifian; R A Mageed; F Shokri
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

Review 6.  The human intestinal B-cell response.

Authors:  J Spencer; L M Sollid
Journal:  Mucosal Immunol       Date:  2016-07-27       Impact factor: 7.313

7.  Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM.

Authors:  A M González; T V Nguyen; M S P Azevedo; K Jeong; F Agarib; C Iosef; K Chang; K Lovgren-Bengtsson; B Morein; L J Saif
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

8.  Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins.

Authors:  Isabelle Schwartz-Cornil; Yann Benureau; Harry Greenberg; Barbara A Hendrickson; Jean Cohen
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  IgA response in preterm neonates shows little evidence of antigen-driven selection.

Authors:  Tobias Rogosch; Sebastian Kerzel; Katharina Hoss; Gabriele Hoersch; Cosima Zemlin; Matthias Heckmann; Claudia Berek; Harry W Schroeder; Rolf F Maier; Michael Zemlin
Journal:  J Immunol       Date:  2012-10-26       Impact factor: 5.422

Review 10.  Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces.

Authors:  Jiri Mestecky; Michael W Russell
Journal:  Immunol Lett       Date:  2009-04-05       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.